Cancer of Head And Neck

General surgery is the common ancestor of all surgical specialties. Within general surgery, many subspecialty areas of practice have evolved. This book is the first manual recognizing the growing role General Surgeons play in Head & Neck Surgery. From benign to malignant conditions and form ablative to reconstructive challenges, the renowned comprehensive capability of the General Surgeon is well suited to demands of this discipline.

Dysphagia and problems related to swallowing are common following treatment for head and neck cancers. Though there are books available on dysphagia management and associated neurological conditions, this is the only atlas that comprehensively discusses dysphagia related to the head and neck cancers. It comprises of 33 chapters divided into five sections. The initial chapters present the anatomy and physiology of swallowing and the pathophysiology of the dysphagia-related structures.

Squamous cell cancers of the head and neck (SCCHN), also known as head and neck cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and pharynx, and are diagnosed in over 500,000 patients worldwide each year, accounting for 5% of all malignancies. It is estimated that approximately 50,000 patients develop head and neck cancer annually in the United States, of whom approximately 50% succumb to this cancer. For most cases of SCCHN, treatment is multimodal, often combining surgery or irradiation with chemotherapy; even successfully treated patients frequently experience durable and severe side effects.